FERRARO, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 240
EU - Europa 83
AS - Asia 27
Totale 350
Nazione #
US - Stati Uniti d'America 238
CN - Cina 22
UA - Ucraina 20
IE - Irlanda 18
FI - Finlandia 10
SE - Svezia 9
IT - Italia 8
NL - Olanda 8
DE - Germania 7
VN - Vietnam 4
GB - Regno Unito 3
CA - Canada 2
SG - Singapore 1
Totale 350
Città #
Chandler 57
Jacksonville 24
Houston 20
Woodbridge 20
Ashburn 19
Beijing 10
Princeton 10
Amsterdam 8
Millbury 6
Los Angeles 5
Boston 4
Dong Ket 4
Dublin 4
Jiaxing 4
Nanjing 4
Wilmington 3
Arienzo 2
Des Moines 2
Bari 1
Boardman 1
Changsha 1
Kronberg 1
Marano Di Napoli 1
Nanchang 1
Napoli 1
New York 1
Nocera Inferiore 1
Ottawa 1
Seattle 1
Shenyang 1
Simi Valley 1
Singapore 1
Tianjin 1
Toronto 1
Washington 1
Totale 223
Nome #
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. 49
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. 47
UbcH10 is overexpressed in malignant breast carcinomas. 41
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 41
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. 39
FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. 37
CDH-16 gene expression in thyroid cell differentiation and transformation. 33
UbcH10 overexpression is less pronounced in older colorectal cancer patients 32
HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas. 26
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. 23
Totale 368
Categoria #
all - tutte 1.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202039 12 0 4 0 4 0 0 0 0 6 7 6
2020/202147 0 4 7 4 5 7 4 0 5 1 6 4
2021/202266 1 0 0 0 0 1 0 3 14 6 26 15
2022/2023102 10 6 4 12 16 14 0 12 14 8 5 1
2023/202441 1 8 4 4 2 7 0 9 1 5 0 0
Totale 368